Upside – $VEEA +45.0% (regained full Nasdaq listing compliance following its reverse stock split) – $XRTX +21.0% (outlined planned FDA IND and Health Canada clinical-trial filings for XRx-026 in gout) – $SAIQ +19.5% (confirmed an October satellite launch advancing its post-quantum secure-communications roadmap) – $HUM +14.5% (2027 CMS Star Ratings exceeded its top-quartile revenue goal, …
Read in context ›Veea Stock (VEEA)
Track Veea stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
VEEA
Veea
technology
At close
$5.11
â–¼ -0.09 (-1.73%)
Oct 14, 4:00 PM ET
After-hours
$5.14
â–² +0.03 (+0.59%)
Oct 14, 6:58 PM ET
Market Cap
$14.34M
P/E Ratio
—
1Y Return
-65.92%
EPS (TTM)
-$1.38
Read the latest TheStreet Pro articles mentioning Veea, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning VEEA yet.
Daily Diary Mentions
2 mentionsUpside, Downside Movers in the Morning Upside, Downside Movers in the Morning Upside – $AEMD +403% (merger agreement with North Immunology adds an IL-13 x IL-18 bispecific-antibody program for atopic dermatitis) – $GNRC +30% (Amazon supply agreement includes $2.4B of backup-generator deliveries expected during 2027-2028) – $VEEA +30% (non-binding combination term sheet with NovaGen targets a $750M AI-health platform) – $DTSS +12% (strategic cooperation expands into AI-powered …
Read in context ›